Clinical trialNCT06881784RecruitingPhase 3Interventional

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

SponsorRevolution Medicines, Inc.Enrollment590NSCLCNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)Non-Small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

152 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Blacktown Medical Oncology Research
Blacktown, New South Wales, Australia
Recruiting
Blacktown Medical Oncology Research, Blacktown Hospital
Blacktown, New South Wales, Australia
Recruiting
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
Recruiting
St. George Private Hospital Clinical Trials Unit
Kogarah, New South Wales, Australia
Recruiting
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Recruiting
Mater Misericordiae Limited
South Brisbane, Queensland, Australia
Recruiting
Alfred House
Melbourne, Victoria, Australia
Recruiting
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Recruiting

Belgium

Institut Jules Bordet
Anderlecht, Belgium, Belgium
Recruiting
Grand Hôpital de Charleroi - Les Viviers
Gilly, Belgium
Recruiting
Az Groeninge
Kortrijk, Belgium
Sofie Derijcke
Recruiting
Uz Leuven-Campus Gasthuisberg
Leuven, Belgium
Recruiting
Az Delta
Roeselare, Belgium
Recruiting

France

Chu Strasbourg - Nouvel Hôpital Civil
Strasbourg, Bas Rhin, France
Celine Mascaux
Recruiting
Hopital Nord - Chu Marseille
Marseille, Bouches-du-Rhône, France
Pascale Tomasini
Recruiting
Institut Régional Du Cancer de Montpellier
Montpellier, Herault, France
Thomas Quentin
Recruiting
Chu Rennes Hôpital Pontchaillou
Rennes, Ille et Vilaine, France
Herva Lena
Recruiting
Chu de Grenoble - Hôpital Albert Michallon
La Tronche, Isere, France
Denis Moro-Sibilot
Recruiting
Chu Nantes - Hôpital Guillaume Et René laënnec
Saint-Herblain, Loire Atlantique, France
Elvire Pons-Tostivint
Recruiting
Institut de Cancerologie de L Ouest
Saint-Herblain, Loire Atlantique, France
Recruiting
Centre Leon Berard
Léon, Lyon, France
Maurice Perol
Recruiting
Hopital Albert Calmette - Chu Lille
Lille, Nord, France
Alexis Cortot
Recruiting
Hôpital Bichat - Claude Bernard
Paris, Paris, France
Recruiting
Hopital Louis Pradel
Bron, Rhone, France
Recruiting
Centre Hospitalier Intercommunal de Créteil
Créteil, Val de Marne, France
Christos Chouaid
Recruiting
Institut Gustave Roussy
Vaillant, Villejuif, France
Recruiting
Chu Brest - Hôpital Morvan
Brest, France
Gilles Quere
Recruiting
Institut Bergonie
Gironde, France
Recruiting
Chu de Toulouse - Hopital Larrey
Toulouse, France
Recruiting

Germany

Lki Lungenfachklinik Immenhausen
Immenhausen, Hesse, Germany
Achim Rittmeyer
Recruiting
Universitaetsklinikum Essen
Essen, North Rhine-Westphalia, Germany
Recruiting
Universitaetsklinikum Carl Gustav Carus Tu Dresden
Dresden, Saxony, Germany
Recruiting
Thoraxklinik Heidelberg Ggmbh
Baden, Wuerttemberg, Germany
Recruiting
Klinikum Esslingen Gmbh
Baden, Germany
Recruiting
Evangelische Lungenklinik Berlin
Berlin, Germany
Recruiting

Hong Kong

Hong Kong United Oncology Centre
Hong Kong, Hong Kong
Recruiting
Queen Mary Hospital
Hong Kong, Hong Kong
Recruiting
the Chinese University of Hong Kong
Shatin, Hong Kong
Recruiting

Ireland

Cork Univeristy Hospital
Cork, Cork, Ireland
Recruiting
Mater Private Hospital
Dublin, Dublin, Ireland
Jane Sui
Recruiting

112 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 May 2025
Primary completion: 1 Dec 2027
Completion: 1 Dec 2030
Last update posted: 7 Jul 2026
Registered enrollment: 590
Registry id: NCT06881784

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.